Morningstar Investor users sign in here.

Company Profile

  • Business description

    Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.

  • Contact

    1700 Owens Street
    Suite 205
    San Francisco CA 94158
    USA

    T: +1 415 660-5320

    E: IR@nurixtx.com

    http://www.nurixtx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 November 2024

    Employees

    284

Stocks News & Analysis

stocks

Going into earnings, Is Apple stock a buy, a sell, or fairly valued?

Watching iPhone revenue, gross margins, and services growth.
stocks

One of the hottest shares on the ASX reports strong growth

Should investors chase this growth story or are they overvalued after the surge in the shares.  
stocks

Diverging value in Australia's real estate sector

One stock dominates Australia's A-REIT index and it has had an incredibly strong year. Our analysts see value elsewhere.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,153.40 59.10 0.73%
CAC 40 7,517.68 90.66 1.22%
DAX 40 18,417.55 118.83 0.65%
Dow JONES (US) 40,589.34 654.27 1.64%
FTSE 100 8,285.71 99.36 1.21%
HKSE 17,021.31 16.34 0.10%
NASDAQ 17,357.88 176.16 1.03%
Nikkei 225 37,667.41 202.10 -0.53%
NZX 50 Index 12,349.47 46.80 -0.38%
S&P 500 5,459.10 59.88 1.11%
S&P/ASX 200 7,921.30 60.10 0.76%
SSE Composite Index 2,890.90 4.16 0.14%

Market Movers

Name
Last price
Change
% Change
Bellevue Gold Ltd BGL 1.44 0.40 -21.58%
Argosy Minerals Ltd AGY 0.05 0.01 41.18%
Red 5 Ltd RED 0.38 0.02 -5.06%
Pilbara Minerals Ltd PLS 2.98 0.11 3.83%
Droneshield Ltd DRO 1.40 0.09 -6.04%
Sayona Mining Ltd SYA 0.03 0.00 0.00%
Core Lithium Ltd CXO 0.10 0.01 6.59%
Zip Co Ltd ZIP 1.78 0.04 -1.93%
South32 Ltd S32 2.98 0.07 2.41%
Telstra Group Ltd TLS 3.85 0.01 0.26%